Abvc Biopharma, Inc. · NASDAQ:ABVC
Abvc Biopharma, Inc. shareholders
As of Jun 30, 2026, 14 institutions reported holding Abvc Biopharma, Inc., 4.1% of its shares. Largest: Vanguard, Geode Capital and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Abvc Biopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 472K | 1.8% | +184K | Aug 13, 2026 |
| Geode Capital | 228K | 0.86% | +6,873 | Aug 12, 2026 |
| State Street | 72,800 | 0.27% | no change | Aug 7, 2026 |
| Citadel | 72,091 | 0.27% | new | Aug 14, 2026 |
| BlackRock | 56,442 | 0.21% | no change | Aug 7, 2026 |
| Northern Trust | 48,643 | 0.18% | +16,556 | Aug 13, 2026 |
| XTX Topco Ltd | 48,276 | 0.18% | new | Aug 14, 2026 |
| Panagora Asset Management Inc | 36,682 | 0.14% | new | Aug 6, 2026 |
| UBS | 34,123 | 0.13% | +32,352 | Aug 13, 2026 |
| Jane Street | 20,059 | 0.08% | new | Aug 14, 2026 |